ctrl K

Price Alert

Eupraxia Pharmaceuticals ... (EPRX)

NASDAQ: EPRX · Real-Time Price · USD

5.32

0.04 (0.76%)

At close: Aug 15, 2025, 3:49 PM

5.30

-0.43%

After-hours: Aug 15, 2025, 04:55 PM EDT

Eupraxia Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	33.1M	19.34M	24.74M	20.89M
Short-Term Investments	n/a	n/a	n/a	9.01M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	80.76K	9.1K	3.37K	31.37K
Receivables	228.87K	n/a	n/a	337.03K
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	270.99K
Total Current Assets	34.44M	19.8M	25.18M	30.6M
Property-Plant & Equipment	424.92K	601.61K	695.48K	589.07K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	505.68K	610.71K	698.85K	620.44K
Total Assets	34.94M	26.72M	25.88M	31.22M
Account Payables	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	13.78M	79.42K	74.44K
Other Current Liabilities	1.49M	3.65M	1.6M	1.4M
Total Current Liabilities	3.1M	25.55M	4.14M	2.27M
Long-Term Debt	n/a	n/a	11.99M	9.26M
Other Long-Term Liabilities	n/a	n/a	-1.67M	29.71K
Total Long-Term Liabilities	n/a	n/a	10.37M	9.4M
Total Liabilities	3.1M	25.55M	14.51M	11.67M
Total Debt	71.86K	10.45M	10.55M	9.56M
Common Stock	116.36M	92.91M	92.34M	80.71M
Retained Earnings	-131M	-105.5M	-97.45M	-74.19M
Comprehensive Income	-4.16M	-3.59M	-2.79M	16.56M
Shareholders Equity	33.4M	2.22M	12.86M	20.39M
Total Investments	n/a	-6.16M	n/a	9.01M